Oxabolone cipionate (INN , JAN ) (brand names Steranabol Depo, Steranabol Ritardo; former developmental code name FI-5852), or oxabolone cypionate, also known as 4-hydroxy-19-nortestosterone 17β-cypionate or estr-4-en-4,17β-diol-3-one 17β-cypionate, is synthetic and injected anabolic–androgenic steroid (AAS) and derivative of nandrolone (19-nortestosterone) which has been marketed in Europe.[1][2][3] It is the C17β cypionate ester and a prodrug of oxabolone (4-hydroxy-19-nortestosterone).[2][3]
Clinical data | |
---|---|
Trade names | Steranabol Depo, Steranabol Ritardo |
Other names | Oxabolone cypionate; FI-5852; 4-Hydroxy-19-nortestosterone 17β-cypionate; Estr-4-en-4,17β-diol-3-one 17β-cypionate |
Routes of administration | Intramuscular injection[1] |
Drug class | Androgen; Anabolic steroid; Androgen ester |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.013.647 |
Chemical and physical data | |
Formula | C26H38O4 |
Molar mass | 414.586 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |